The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent

American Journal of Surgical Pathology

Volumn 30, Issue 11, 2006, Pages 1367-1371

  Silva, Elvio G ^a,b   Gershenson, David M ^a   Malpica, Anais ^a   Deavers, Michael ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Implant; Noninvasive implant; Ovary; Recurrence; Serous borderline tumor; Serous neoplasm of low malignant potential

Indexed keywords

ANTINEOPLASTIC AGENT;

ABDOMINAL HYSTERECTOMY; ADOLESCENT; ADULT; AGED; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FOLLOW UP; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEDICAL RECORD; OVARY TUMOR; OVERALL SURVIVAL; RECURRENCE RISK; REVIEW; SALPINGOOOPHORECTOMY; STAINING; TUMOR BIOPSY;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; CYSTADENOCARCINOMA, SEROUS; FEMALE; FOLLOW-UP STUDIES; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; RADIOTHERAPY; SURVIVAL RATE; TIME FACTORS;

EID: 33750438467     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000213294.81154.95     Document Type: Review

References (18)

1. Bell DA, Weinstock MA, Scully RE. Peritoneal implants of serous borderline tumors: histologic features and prognosis. Cancer. 1988;62:2212-2222.
2. Bostwick DG, Tazelaar HD, Ballon SC, et al. Ovarian epithelial tumors of borderline malignancy. A clinical and pathologic study of 109 cases. Cancer. 1986;58:2052-2065.
3. Crispens MA, Bodurka D, Deavers M, et al. Response and survival in patients with progressive or recurrent serous ovarian tumors of low malignant potential. ACOG. 2002;99:3-10.
4. Deavers MT, Gershenson DM, Tortolero-Luna G, et al. Micropapillary and cribriform patterns in ovarian serous tumors of low malignant potential. A study of 99 advanced-stage cases. Am J Surg Pathol. 2002;26:1129-1141.
5. Dietel M, Hauptmann S. Serous tumors of low malignant potential of the ovary. Diagnostic Pathology. Virchows Arch. 2000;436:403-412.
6. Eichhorn JH, Bell DA, Young RH, et al. Ovarian serous borderline tumors with micropapillary and cribriform patterns: a study of 40 cases and comparison with 44 cases without these patterns. Am J Surg Pathol. 1999;23:397-409.
7. Gershenson DM, Silva EG. Serous ovarian tumors of low malignant potential with peritoneal implants. Cancer. 1990;65:578-585.
8. Gilks CB, Alkushi A, Yue JJW, et al. Advanced-stage serous borderline tumors of the ovary: a clinicopathological study of 49 cases. Int J Gynecol Pathol. 2002;22:39-36.
9. Julian CG, Woodruff JD. The biologic behavior of low-grade papillary serous carcinoma of the ovary. Obstet Gynecol. 1972;40:860-867.
10. Kennedy AW, Hart WR. Ovarian papillary serous tumors of low malignant potential (serous borderline tumors): a long term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma. Cancer. 1996;78:278-286.
11. Kurman RJ, Trimble CL. The behavior of serous tumors of low malignant potential: are they ever malignant? Int J Gynecol Pathol. 1993;12:120-127.
12. Lackman F, Carey MS, Kirk ME, et al. Surgery as sole treatment for serous borderline tumors of the ovary with noninvasive implants. Gynecol Oncol. 2003;90:407-412.
13. Leake JF, Currie JL, Rosenshein NB, et al. Long-term follow-up of serous ovarian tumors of low malignant potential. Gynecol Oncol. 1992;47:150-158.
14. Malpica A, Deavers MT, Lu K, et al. Grading ovarian serous carcinoma using a two-tier system. Am J Surg Pathol. 2004;28:496-504.
15. McCaughey WTE, Kirk ME, Lester W, et al. Peritoneal epithelial lesions associated with proliferative serous tumors of ovary. Histopathology. 1984;8:195-208.
16. Prat J, deNictolis M. Serous borderline tumors of the ovary. A long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion. Am J Surg Pathol. 2002;26:1111-1128.
17. Seidman JD, Kurman RJ. Subclassification of serous borderline tumors of the ovary into benign and malignant types. Am J Surg Pathol. 1996;20:1331-1345.
18. Seidman JD, Kurman RJ. Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Hum Pathol. 2000;31:539-557.